Literature DB >> 12174775

Taenia solium cysticercosis in a village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen.

Annette Erhart1, Pierre Dorny, Nguyen Van De, Ha Viet Vien, Dang Cam Thach, Nguyen Duy Toan, Le Dinh Cong, Stanny Geerts, Niko Speybroeck, Dirk Berkvens, Jef Brandt.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for detecting circulating Taenia solium antigen was evaluated in Viet Nam; 12 of 210 people gave a positive result, including 5 persons with epilepsy. Cysticercosis was confirmed in 9 persons. Agreement between the ELISA, computerized tomography scanning and biopsy examination was high.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12174775     DOI： 10.1016/s0035-9203(02)90095-7

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


  17 in total

1.  Infection with versus exposure to Taenia solium: what do serological test results tell us?

Authors:  Nicolas Praet; Richar Rodriguez-Hidalgo; Niko Speybroeck; Serge Ahounou; Washington Benitez-Ortiz; Dirk Berkvens; Anke Van Hul; Margoth Barrionuevo-Samaniego; Claude Saegerman; Pierre Dorny
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 2.  Neurocysticercosis: a review on status in India, management, and current therapeutic interventions.

Authors:  Rumana Ahmad; Tahmeena Khan; Bilal Ahmad; Aparna Misra; Anil K Balapure
Journal:  Parasitol Res       Date:  2016-10-24       Impact factor: 2.289

3.  Detection of Taenia solium DNA in the Urine of Neurocysticercosis Patients.

Authors:  Luz Toribio; Miryam Romano; Alan L Scott; Isidro Gonzales; Herbert Saavedra; Hector H Garcia; Clive Shiff
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 2.345

4.  In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.

Authors:  Adriana Paredes; Tiago de Campos Lourenço; Miguel Marzal; Andrea Rivera; Pierre Dorny; Siddhartha Mahanty; Cristina Guerra-Giraldez; Hector H García; Theodore E Nash; Quezia B Cass
Journal:  Antimicrob Agents Chemother       Date:  2012-12-10       Impact factor: 5.191

Review 5.  Epidemiology, clinical manifestations and diagnosis of zoonotic cestode infections: an update.

Authors:  W Raether; H Hänel
Journal:  Parasitol Res       Date:  2003-09-16       Impact factor: 2.289

6.  A cross-sectional study of Taenia solium in a multiple taeniid-endemic region reveals competition may be protective.

Authors:  James V Conlan; Khamphouth Vongxay; Boualam Khamlome; Pierre Dorny; Banchob Sripa; Aileen Elliot; Stuart D Blacksell; Stanley Fenwick; R C Andrew Thompson
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

Review 7.  A research agenda for helminth diseases of humans: diagnostics for control and elimination programmes.

Authors:  James S McCarthy; Sara Lustigman; Guo-Jing Yang; Rashida M Barakat; Héctor H García; Banchob Sripa; Arve Lee Willingham; Roger K Prichard; María-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2012-04-24

Review 8.  Taenia solium Human Cysticercosis: A Systematic Review of Sero-epidemiological Data from Endemic Zones around the World.

Authors:  Marco Coral-Almeida; Sarah Gabriël; Emmanuel Nji Abatih; Nicolas Praet; Washington Benitez; Pierre Dorny
Journal:  PLoS Negl Trop Dis       Date:  2015-07-06

9.  Seroprevalence to the antigens of Taenia solium cysticercosis among residents of three villages in Burkina Faso: a cross-sectional study.

Authors:  Hélène Carabin; Athanase Millogo; Nicolas Praet; Sennen Hounton; Zékiba Tarnagda; Rasmané Ganaba; Pierre Dorny; Pascal Nitiéma; Linda D Cowan
Journal:  PLoS Negl Trop Dis       Date:  2009-11-24

10.  Added value of antigen ELISA in the diagnosis of neurocysticercosis in resource poor settings.

Authors:  Sarah Gabriël; Joachim Blocher; Pierre Dorny; Emmanuel Nji Abatih; Erich Schmutzhard; Michaeli Ombay; Bartholomayo Mathias; Andrea Sylvia Winkler
Journal:  PLoS Negl Trop Dis       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.